GAINESVILLE, Fla., Feb. 14, 2012 (GLOBE NEWSWIRE) -- Quick-Med Technologies, Inc. (OTCQB:QMDT.PK - News), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that it has amended the license previously granted to Viridis BioPharma to include a new antimicrobial polyurethane foam dressing that utilizes Quick-Med’s proprietary NIMBUS(R) technology and that Viridis has received approval from the Food and Drug Administration of India to manufacture and market the dressings. This is the first of several NIMBUS advanced wound care formats that are in development.
